Kazia Therapeutics Ltd ADR Capital Reinvestment Ratio

Latest as of September 2021: 0.50x

Kazia Therapeutics Ltd ADR capital reinvestment ratio. Kazia Therapeutics Ltd ADR (KZIA) has a Capital Reinvestment Ratio of 0.50x as of September 2021, meaning it reinvests 1% of its operating cash flow ($3.16 Million) in capital expenditures ($1.58 Million). Check Kazia Therapeutics Ltd ADR (KZIA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.50x

Capex / Operating Cash Flow

Operating Cash Flow

$3.16 Million

USD

Capital Expenditures

$1.58 Million

USD

Data as of

Sep 2021

Most recent filing

Kazia Therapeutics Ltd ADR Capital Reinvestment Ratio by Year (None–None)

Kazia Therapeutics Ltd ADR capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Kazia Therapeutics Ltd ADR cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow